Clinical Trials Logo

Clinical Trial Summary

To estimate peripheral perfusion in shock state, international guidelines recommend the use of capillary refill time, and practitioners currently evaluates it at bedside. However its measurement is not standardized, what should explain the large observer variability reported in different studies. Hence, a device providing a standardized evaluation seems to be helpful. The aim of the study is to evaluate diagnostic performance of such a device recently developped (DiCART TM), in healthy volunteers experiencing vascular occlusion tests to induce impaired perfusion.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04538612
Study type Interventional
Source Hospices Civils de Lyon
Contact
Status Completed
Phase N/A
Start date January 28, 2020
Completion date July 10, 2020

See also
  Status Clinical Trial Phase
Terminated NCT04366310 - Capillary Refill Index With Rewarming
Completed NCT02394366 - Topical Salve for Skin Oxygenation and Blood Flow Phase 2
Completed NCT03078712 - Early Goal Directed Therapy Using a Physiological Holistic View. The ANDROMEDA-SHOCK Study N/A
Completed NCT04040478 - Transcutaneous Monitoring of Oxygen and Carbon Dioxide in Surgical Patients
Recruiting NCT03762005 - Peripheral Perfusion Versus Lactate Targeted Fluid Resuscitation in Septic Shock N/A
Completed NCT02771002 - Assessment of Peripheral Perfusion in the Critically Ill Patient N/A
Completed NCT03845361 - Radial Artery Cannulation and Perfusion Index N/A
Completed NCT04688203 - Effects Magnesium Sulfate and Labetalol Infusion on Peripheral Perfusion and Pain in Nasal Surgeries Phase 1/Phase 2
Recruiting NCT04043481 - Modified Allen's Test and Peripheral Perfusion Index
Completed NCT03395483 - Peripheral and Mesenteric Perfusion in Elective Surgical Patients